fashion -WSS

fashion

author：explore 2025-09-02 11:46:18 - browse：89842

George Yancopoulos on the 2024 Breakthrough Summit East stage. — George Yancopoulos on the 2024 Breakthrough Summit East stage STAT

George Yancopoulos is in touch with his teenage self.

After 35 years as head scientist at Regeneron Pharmaceuticals, Yancopoulos has led the development of 12 approved medicines, turning a once-fledgling company into the $100 billion global drugmaker it is today. And you can trace a straight line back to the childhood fascination with science he fostered growing up in Woodside, Queens.

“My high school science project was about regenerating neurons, and ‘Regeneron’ is a contraction of ‘regenerating neurons,’” Yancopoulos said at the STAT Summit East on Thursday. “In some ways I’m still working on my high school science project.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Physician assistants need a new name. Here's what it should be

WSS

Scientists boost immune system in aging mice by making it youthful

Food as medicine: Medically tailored meals may get standardized

American taxpayers paid $1.8 trillion in health care costs in 2022

A preacher's new calling: Diversifying neuroscience research

Roche subsidiary Foundation Medicine opens new headquarters

Donor acceptance rates hint at racial, gender bias in heart transplants: study

focus

fashion

explore

Wildfire smoke exposes gaps in outdoor worker protections

Study suggests new cause of Down syndrome: cells linked to aging

Virginia high school admissions case could be legal follow

Medicare Advantage overpayments discussion gets experts fired up

Moonlake's readout produced a cash windfall. Risks remain

Medicare Advantage coverage denials need scrutiny, senators say

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Donor acceptance rates hint at racial, gender bias in heart transplants: study

23andMe had bad news about my health. I wish a person had delivered it

Allen Institute goes after foundational questions, CEO Costa says

entertainment

Will generative AI in health care meet the fate of IBM's Dr. Watson?

Washington mulls new rules to avert another Change Healthcare

Will generative AI in health care meet the fate of IBM's Dr. Watson?

Physician assistants need a new name. Here's what it should be

Stories you might have missed in 2023: health, science, medicine

Supreme Court mifepristone arguments center on docs' right to sue

hotspot

Wikipedia

entertainment

hotspot